Literature DB >> 7038488

Recent developments in "nonspecific" inflammatory bowel disease (first of two parts).

J B Kirsner, R G Shorter.   

Abstract

Entities:  

Mesh:

Year:  1982        PMID: 7038488     DOI: 10.1056/NEJM198204013061304

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  50 in total

1.  Carbonylation and disassembly of the F-actin cytoskeleton in oxidant induced barrier dysfunction and its prevention by epidermal growth factor and transforming growth factor alpha in a human colonic cell line.

Authors:  A Banan; Y Zhang; J Losurdo; A Keshavarzian
Journal:  Gut       Date:  2000-06       Impact factor: 23.059

Review 2.  Clinical aspects and pathophysiology of inflammatory bowel disease.

Authors:  Barbara A Hendrickson; Ranjana Gokhale; Judy H Cho
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

Review 3.  Inflammatory intermediaries in inflammatory bowel disease.

Authors:  K Lauritsen; L S Laursen; K Bukhave; J Rask-Madsen
Journal:  Int J Colorectal Dis       Date:  1989       Impact factor: 2.571

4.  Metabolic induction of experimental ulcerative colitis by inhibition of fatty acid oxidation.

Authors:  W E Roediger; S Nance
Journal:  Br J Exp Pathol       Date:  1986-12

5.  Erythrocyte deformability and oxidative stress in inflammatory bowel disease.

Authors:  Tulay Akman; Mesut Akarsu; Hale Akpinar; Halil Resmi; Ebru Taylan; Ebru Sezer
Journal:  Dig Dis Sci       Date:  2011-09-08       Impact factor: 3.199

6.  Indomethacin-induced intestinal ulcers in rats: effects of salicylazosulfapyridine and dexamethasone.

Authors:  P Del Soldato; D Foschi; L Varin; S Daniotti
Journal:  Agents Actions       Date:  1985-07

7.  Supraphysiologic extracellular pressure inhibits intestinal epithelial wound healing independently of luminal nutrient flow.

Authors:  Thomas L Flanigan; Cheri R Owen; Christopher Gayer; Marc D Basson
Journal:  Am J Surg       Date:  2008-11       Impact factor: 2.565

8.  A stable nitroxide radical effectively decreases mucosal damage in experimental colitis.

Authors:  F Karmeli; R Eliakim; E Okon; A Samuni; D Rachmilewitz
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

9.  Smoking and Crohn's disease.

Authors:  K W Somerville; R F Logan; M Edmond; M J Langman
Journal:  Br Med J (Clin Res Ed)       Date:  1984-10-13

10.  Increased production of luminol enhanced chemiluminescence by the inflamed colonic mucosa in patients with ulcerative colitis.

Authors:  S Sedghi; J Z Fields; M Klamut; G Urban; M Durkin; D Winship; D Fretland; M Olyaee; A Keshavarzian
Journal:  Gut       Date:  1993-09       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.